ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $341,000 | -67.8% | 4,059 | -63.5% | 0.01% | -68.0% |
| Q1 2019 | $1,058,000 | -42.9% | 11,130 | -57.4% | 0.02% | -46.8% |
| Q4 2018 | $1,854,000 | -31.3% | 26,143 | -17.9% | 0.05% | -14.5% |
| Q3 2018 | $2,698,000 | -26.4% | 31,826 | +0.0% | 0.06% | -29.5% |
| Q2 2018 | $3,666,000 | +68.1% | 31,817 | +18.1% | 0.08% | +62.5% |
| Q1 2018 | $2,181,000 | +558.9% | 26,951 | +377.8% | 0.05% | +500.0% |
| Q4 2017 | $331,000 | – | 5,641 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |